Bryn Mawr Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.96M | Sell |
|
|||||
|
2025
Q2 | $1.87M | Buy |
|
|||||
|
2025
Q1 | $1.75M | Sell |
|
|||||
|
2024
Q4 | $1.91M | Sell |
|
|||||
|
2024
Q3 | $2.44M | Sell |
|
|||||
|
2024
Q2 | $5.43M | Sell |
|
|||||
|
2024
Q1 | $5.56M | Buy |
|
|||||
|
2023
Q4 | $5.02M | Sell |
|
|||||
|
2023
Q3 | $8.08M | Buy |
|
|||||
|
2023
Q2 | $8.07M | Buy |
|
|||||
|
2023
Q1 | $8.49M | Sell |
|
|||||
|
2022
Q4 | $11.1M | Buy |
|
|||||
|
2022
Q3 | $532K | Sell |
|
|||||
|
2022
Q2 | $641K | Sell |
|
|||||
|
2022
Q1 | $654K | Buy |
|
|||||
|
2021
Q4 | $714K | Sell |
|
|||||
|
2021
Q3 | $525K | Buy |
|
|||||
|
2021
Q2 | $397K | Hold |
|
|||||
|
2021
Q1 | $367K | Buy |
|
|||||
|
2020
Q4 | $371K | Sell |
|
|||||
|
2020
Q3 | $392K | Buy |
|
|||||
|
2020
Q2 | $285K | Sell |
|
|||||
|
2020
Q1 | $404K | Sell |
|
|||||
|
2019
Q4 | $488K | Buy |
|
|||||
|
2019
Q3 | $441K | Sell |
|
|||||
|
2019
Q2 | $592K | Buy |
|
|||||
|
2019
Q1 | $475K | Sell |
|
|||||
|
2018
Q4 | $520K | Sell |
|
|||||
|
2018
Q3 | $527K | Sell |
|
|||||
|
2018
Q2 | $456K | Buy |
|
|||||
|
2018
Q1 | $439K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $436K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $442K | Buy |
|
|||||
|
2016
Q4 | $410K | Buy |
|